New York Gov. Andrew Cuomo has announced that Regeneron, a biotechnology company that invents and manufactures life-transforming medicines for people with serious diseases, intends to invest approximately $1.8 billion over six years to expand its research, preclinical manufacturing and support facilities at the company's Westchester County campus in Tarrytown, N.Y., and create 1,000 new full-time, high-skill jobs in the Mid-Hudson region over the next five years.
To encourage Regeneron's continued expansion in New York state, Empire State Development offered the company up to $100 million in Excelsior Jobs Program tax credits if its hiring goals are achieved. Regeneron considered several potential sites in the Tri-state area before deciding to expand in the Mid-Hudson region.
Regeneron president and CEO Leonard Schleifer said, "The COVID-19 pandemic has highlighted the importance of continued and long-term investment in the biopharmaceutical industry, and Regeneron is
